Abstract
The immune responses elicited by measles virus (MV) in many ways define the epidemiology and the illnesses produced by infection. During a study of the 1886 epidemic of measles in the Faroe Islands, the young Danish physician Peter Panum identified not only the highly infectious nature of the virus, but also the 14 day incubation period before the onset of the rash, the severity of the disease in infants and the presence of lifelong immunity in the absence of reexposure in elderly residents (Panum 1938). In 1908 another observant physician, von Pirquet, reported the loss of skin test reactivity and the reactivation of tuberculosis after measles that occurred in the residents of a Viennese tuberculosis sanitarium (VON Pirquet 1908). In 1790 James Lucas, a surgeon from Leeds, described the first case of post-measles encephalomyelitis (Lucas 1790). Thus, by early in the twentieth century most of the features of the disease that we now seek to understand, using the knowledge and tools of modern immunology, had been established.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aicardi J, Goutieres F et al. (1977) Acute measles encephalitis in children with immunosuppression. Pediatrics 59: 232–239
Albrecht P, Ennis FA et al. (1977) Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J Pediatr 91: 715–178
Annunziato D, Kaplan MH et al. (1982) Atypical measles syndrome: pathologic and serologic findings. Pediatrics 70: 203–209
Arneborn P, Biberfeld G (1983) T lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun 39: 29–37
Barrett PN, Koschel K et al. (1985) Effect of measles virus antibodies on a measles SSPE virus persistently infected C6 rat glioma cell line. J Gen Virol 66: 1411–1421
Bech V (1959) Studies on the development of complement fixing antibodies in measles patients. J Immunol 83: 267–275
Beckford AP, Kaschula ROC et al. (1985) Factors associated with fatal cases of measles: A retrospective autopsy study. S Afr Med J 68: 858–863
Bellanti JA, Sanga RL et al. (1969) Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med 280: 628–633
Bellini WJ, McFarlin DE et al. (1981) Immune reactivity of purified hemagglutinin of measles virus. Infect Immun 32: 1051–1057
Black FL (1989) Measles active and passive immunity in a worldwide perspective. Prog Med Virol 36: 1–33
Brajczewska-Fischer W, Iwinska B et al. (1989) Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerabation of multiple sclerosis. Acta Neurol Scand 80: 390–393
Brodsky AL (1972) Atypical measles: severe illness in recipients of killed measles virus vaccine upon exposure to natural infection. J Am Med Assoc 222: 1415–1416
Buckland R, Giraudon P et al. (1989) Expression of measles virus nucleoprotein in Escherichia coli: use of deletion mutants to locate the antigenic sites. J Gen Virol 70: 435–441
Buser F (1967) Side reaction to measles vaccination suggesting the arthus phenomenon. N Engl J Med 277: 250–251
Carter CH, Conway TJ et al. (1962) Serologic response of children to inactivated measles vaccine. JAMA 179: 848–853
Carter MJ, Willcocks MM et al. (1982) Relationships between monoclonal antibody-binding sites on the measles virus haemagglutinin. J Gen Virol 63: 113–120
Cherry JD, Feigin RD et al. (1972) Atypical measles in children previously immunized with attenuated measles virus vaccines. Pediatrics 50: 712–717
Connolly JH, Allen IV et al. (1967) Measles virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1: 542–544
Coovadia HM, Wesley A et al. (1981) Measles, histocompatibility leukocyte antigen polymorphism, and natural selection in humans. J Infect Dis 144: 142–147
Crespi M, Struthers JK et al. (1988) Interferon status after measles virus infection. S Afr Med J 73: 711–712
Dhib-Jalbut S, Jacobson S et al. (1989) Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis. Ann Neurol 25: 272–280
Donaldson SL, Kosco MH et al. (1986) Localization of antibody-forming cells in draining lymphoid organs during long-term maintenance of the antibody response. J Leukoc Biol 40: 147–157
Ehrnst AC (1975) Characterization of measles virus-specific cytotoxic antibodies by use of a chronically infected cell line. J Immunol 114: 1077–1082
Ehrnst A (1978) Separate pathways of C activation by measles virus cytotoxic antibodies: subclass analysis and capacity of F (ab) molecules to activate C via the alternative pathway. J Immunol 121:1206–1212
Enders JF, McCarthy K et al. (1959) Isolation of measles virus at autopsy in cases of giant cell pneumonia without rash. N Engl J Med 261: 875–881
Enders-Ruckle G (1967) Some characteristics of immunity following natural measles and various forms of immunization. Arch Gesamte Virusforsch 22: 23–34
Esiri MM, Oppenheimer DR et al. (1982) Distribution of measles antigen and immunoglobulin containing cells in the CNS in subacute sclerosing panencephalitis (SSPE) and atypical measles encephalitis. J Neurol Sci 53: 29–43
Esolen LM, Ward BJ et al. (1993) Infection of monocytes during measles. J Infect Dis 168: 47–52
Fireman P, Friday G et al. (1969) Effect of measles virus vaccine on immunologic responsiveness. Pediatrics 43: 264–272
Fujinami RS, Oldstone MBA (1979) Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature 279: 529–530
Fulginiti VA, Arthur JH (1969) Altered reactivity to measles virus. J Pediatr 75: 609–616
Fulginiti VA, Arthur JH et al. (1968) Altered reactivity to measles virus local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines. Am J Dis Child 115: 67–72
Furukawa S, Matsubara T et al. (1992) Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 151: 44–47
Garenne M, Leroy O et al. (1991) Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338: 903–907
Gendelman H, Wolinsky JS et al. (1984) Measles encephalitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination. Ann Neurol 15: 353–360
Goretsky M (1990) Acute fatal leukoencephalopathy after interleukin-2 therapy. N Engl J Med 323: 1146–1147
Graves M, Griffin DE et al. (1984) Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J Virol 49: 409–412
Gray D, Skarvall H (1988) B-cell memory is short-lived in the absence of antigen. Nature 336: 70–73
Greenstein JI, McFarland HF (1983) Response of human lymphocytes to measles virus after natural infection. Infect Immun 40: 198–204
Griffin DE, Ward BJ (1993) Differential CD4 T cell activation in measles. J Infect Dis 168: 275–281
Griffin DE, Cooper SJ et al. (1985) Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J Allergy Clin Immunol 76: 206–213
Griffin DE, Moench TR et al. (1986) Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol 40: 305–312
Griffin DE, Johnson RT et al. (1987) In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections. Clin Immunol Immunopathol 45: 375–383
Griffin DE, Moench TR et al. (1986) Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol 40: 305–312
Griffin DE, Ward BJ et al. (1989) Immune activation during measles. N Engl J Med 320: 1667–1672
Griffin DE, Ward BJ et al. (1990a) Immune activation during measles: Interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease J Infect Dis 161: 449–453
Griffin DE, Ward BJ et al. (1990b) Natural killer cell activity during measles. Clin Exp Immunol 81: 218–224
Griffin DE, Ward BJ et al. (1992) Immune activation during measles: Beta-2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Infect Dis 166: 1170–1173
Haddad FS, Risk WS et al. (1977) Subacute sclerosing panencephalitis in the Middle East: report of 99 cases. Ann Neurol 1: 211–217
Hall WW, Lamb RA et al. (1979) Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci USA 76: 2047–2051
Halsey NA, Boulos R et al. (1985) Response to measles vaccine in Haitian infants 6 to 12 months old. N Engl J Med 313: 544–549
Hirsch RL, Mokhtarian F et al. (1981) Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production. Clin Immunol Immunopathol 21: 341–350
Hirsch RL, Griffin DE et al. (1984) Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 31: 1–12
Hofman FM, Hinton DR et al. (1991) Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 58: 331–342
Ilonen J, Makela MJ et al. (1990) Cloning of human T cells specific for measles virus haemagglutinin and nucleocapsid. Clin Exp Immunol 81: 212–217
Jacobson S, Richert JR et al. (1984) Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol 133: 754–757
Jacobson S, Sekaly RP et al. (1989) HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J Virol 63: 1756–1762
Joffe MI, Rabson AR (1981) Defective helper factor (LMC) production in patients with acute measles infection. Clin Immunol Immunopathol 20: 215–223
Johnson RT, Griffin DE et al. (1984) Measles encephalomyelitis—clinical and immunologic studies. N Engl J Med 310: 137–141
Joseph BS, Oldstone BA (1975) Immunologic injury in measles virus infection II. Suppression of immune injury through antigenic modulation. J Exp Med 142: 864–876
Joseph BS, Lampert PW et al. (1975) Replication and persistence of measles virus in defined subpopulations of human leukocytes. J Virol 16: 1638–1649
Kaplan LJ, Daum RS et al. (1992) Severe measles in immunocompromised patients. JAMA 267: 1237–1241
King JC Jr, Lichnestein R et al. (1993) Measles, mumps, and rubella antibodies in vaccinated Baltimore children. Amer J Dis Child 147: 558–560
Krause PJ, Cherry JD et al. (1978) Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies. J Pediatr 93: 565–571
Kreth HW, ter Meulen V et al. (1979) Demonstration of HLA restricted killer cells in patients with acute measles. Med Microbiol Immunol 165: 203–214
Larner AC, Petricoin EF et al. (1993) IL-4 attenuates the transcriptional activation of both IFN-alpha and IFN-gamma-induced cellular gene expression in monocytes and monocytic cell lines. J Immunol 150:1944–1950
Leopardi R, Ilonen J et al. (1993) Effect of measles virus infection on MHC class II expression and antigen presentation in human monocytes. Cell Immunol 147: 388–396
Leopardi R, Vainionpaa R et al. (1992) Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes. J Immunol 149: 2397–2401
Litvak AM, Sands IJ et al. (1943) Encephalitis complicating measles: report of fifty-six cases with followup studies in thirty-two. Am J Dis Child 65: 265–295
Lucas CJ, Biddison WE et al. (1982) Killing of measles virus-infected cells by human cytotoxic T cells. Infect Immun 38: 226–232
Lucas J (1790) An account of uncommon symptoms succeeding the measles; with additional remarks on the infection of measles and smallpox. Lond Med J 11: 325–331
Machamer CE, Hayes EC et al. (1980) Antibodies against the measles matrix polypeptide after clinical infection and vaccination. Infect Immun 27: 817–825
Malvoisin E, Wild F (1990) Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J Virol 64: 5160–5162
Mandalenaki-Asfi C, Liakopoulou P et al. (1976) Rosette-forming lymphocytes and measles vaccination. J Pediatr 88: 74–75
Markowitz LE, Chandler FW et al. (1988) Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis 158: 480–483
Markowitz LE, Preblud SR et al. (1990) Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J 9: 101–110
Martin DB, Weiner LB et al. (1979) Atypical measles in adolescents and young adults. Ann Intern Med 90:877–881
Martinez OM, Gibbons RS et al. (1990) IL-4 inhibits IL-2 receptor expression and IL-2 dependent proliferation of human T cells. J Immunol 144: 2211–2215
Mathiesen T, Hammarstrom L et al. (1990) Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients. Clin Exp Immunol 80: 202–205
Mehta PD, Kulczycki J et al. (1992) Increased levels of beta-2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis. Clin Immunol Immunopathol 65: 53–59
Merz DC, Scheid A et al. (1980) Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med 151: 275–288
Miller DL (1964) Frequency of complications of measles. 1963 Br Med J 2: 75–78
Mitus A, Enders JF et al. (1959) Persistence of measles virus and depression of antibody formation in patients with giant-cell pneumonia after measles. N Engl J Med 261: 882–889
Moench TR, Griffin DE et al. (1988) Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 158: 433–442
Morley D (1969) Severe measles in the tropics. Br Med J 1: 297–300
Mosmann TR, Coffman RL (1987) Two types of mouse helper T cell clone: implications for immune regulation. Immunol Today 8: 223–227
Mustafa MM, Weitman SD et al. (1993) Subacute measles encephalitis in the young immuno-compromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 16: 654–660
Nader PR, Horwitz MS et al. (1968) Atypical exanthem following exposure to natural rneasles: eleven cases in children previously inoculated with killed vaccine. J Pediatr 72: 22–28
Nagano I, Nakamura S et al. (1991) Immunocytochemical analysis of the cellular infiltrate in brain lesions in subcute sclerosing panencephalitis. Neurology 41 : 1639–1642
Nelson JD, Sandusky G et al. (1966) Measles skin test and serologic response to intradermal measles antigen. JAMA 198: 185–186
Norrby E, Enders-Ruckle G et al. (1975) Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis 132: 262
Norrby E, Gollmar Y (1972) Appearance and persistence of antibodies against different virus components after regular measles infections Infect. Immun 6: 240–247
Norrby E, Gollmar Y (1975) Identification of measles virus-specific hemolysis-inhibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun 11: 231–239
Norrby E, Orvell C et al. (1981) Antibodies against measles virus polypeptides in different disease conditions. Infect Immun 34: 718–724
Panum P (1938) Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Class 3: 829–886
Patrick BA, Mehta PD et al. (1990) Measles virus-specific immunoglobulin D antibody in cerebrospinal fluid and serum from patients with subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 26: 69–74
Rammohan KW, McFarland HF et al. (1983) Antibody-mediated modification of encephalitis induced by hamster neurotropic measles virus. J Infect Dis 147: 546–550
Rauh LW, Schmidt R (1965) Measles immunization with killed virus vaccine. Am J Dis Child 109: 232–237
Rose JW, Bellini WJ et al. (1984) Human cellular immune response to measles virus polypeptides. J Virol 49: 988–991
Rota JS, Hummel KB et al. (1992) Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188: 135–142
Ruckle G, Rogers KD (1957) Studies with measles virus. II. Isolation of virus and immunologic studies in persons who have had the natural disease. J Immunol 78: 341–355
Salonen R, Ilonen J et al. (1988) Measles virusn vitro: antigen expression and virus production preferentially in monocytes. Clin Exp Immunol 71: 224–228
Schluederberg A (1965) Immune globulins in human viral infections. Nature 205: 1232–1233
Schneider-Schaulies S, Liebert UG et al. (1992) Antibody-dependent transcriptional regulation of measles virus in persistently infected neural cells. J Virol 66: 5534–5541
Scott TFM, Bonanno DE (1967) Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine. N Engl J Med 277: 248–250
Sheshberadaran H, Norrby E (1986) Characterization of epitopes on the measles virus hemagglutinin. Virology 152: 58–65
Shiozawa S, Yoshikawa N et al. (1988) A sensitive radioimmunoassay for circulating alpha-interferon in the plasma of healthy children and patients with measles virus infection. Clin Exp Immunol 73: 366–369
Siber GR, Werner BG et al. (1993) Interference of immune globulin with measles and rubella immunization. J Pediatr 122: 204–211
Sotrel A, Rosen S et al. (1983) Subacute sclerosing panencephalitis: an immune complex disease? Neurology 33: 885–890
Stephenson JR, ter Meulen V (1979) Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides. Proc Natl Acad Sci USA 76: 6601–6605
Sullivan JL, Barry DW et al. (1975) Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med 142: 773–784
Tamashiro VG, Perez HH et al. (1987) Prospective study of the magnitude and duration of changes in tuberculin reactivity during complicated and uncomplicated measles. Pediatr Infect Dis J 6: 451–454
Taylor MJ, Godfrey E et al. (1991) Identification of several different lineages of measles virus. J Gen Virol 72: 83–88
ter Meulen V, Loffler S et al. (1981) Antigenic characterization of measles and SSPE virus haemagglutinin by monoclonal antibodies. J Gen Virol 67: 357–364
Tew JG, Kosco MH et al. (1990) Follicular dendritic cells as accessory cells. Immunol Rev 117: 185–211
Tourtellotte WW, Ma BI et al. (1981) Quantification of de novo central nervous system IgG measles antibody synthesis in SSPE. Ann Neurol 9: 551–556
Trudgett A, Gould EA et al. (1981) Antigenic difference in the hemagglutinin of measles and related viruses. Virology 109: 180–182
van Binnendijk R, Poelen MCM et al. (1989) Measles virus-specific human T cell clones. Characterization of specificity and function of CD4 helper/cytotoxic and CD8+ cytotoxic T cell clones. J Immunol 142: 2847–2854
van Binnendijk RS, Poelen MCM et al. (1990) The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. J Immunol 144: 2394–2399
van Binnendijk RS, van Baalen CA et al. (1992) Measles virus transmembrane fusion protein systhesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II- restricted cytotoxic T cell recognition. J Exp Med 176: 119–128
van Binnendijk RS, Versteeg-van Oosten JPM et al. (1993) Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J Virol 67: 2276–2284
Vandvik B, Norrby E (1973) Oligocional lgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci USA 70: 1060–1063
Von Pirquet C (1908) Verhalten der kutanen Tuberkulinreaktion wahrend der Masern. Dtsch Med Wochenschr 34: 1297–1300
Ward BJ, Griffin DE (1993) Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol lmmunopathol 67: 171–177
Ward BJ, Johnson RT et al. (1990) Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: identification of dividing cells and correlation with mitogen responsiveness. Clin Immunol Immunopathol 55: 315–326
Ward BJ, Johnson RT et al. (1991) Cytokine production in vitro and the Iymphoproliferative defect of natural measles virus infection. Clin Immunol lmmunopathol 61: 236–248
Weil ML, Leiva WA et al. (1975) Release of bound immunoglobulin from SSPE brain by acid elution. J Immunol 115: 1603–1606
Wiesmuller K-H, Handtmann D et al. (1992) Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera. J Gen Virol 73: 2211–2216
Wild TF, Malvoisin E et al. (1991) Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72: 439–442
Wu VH, McFarland H et al. (1993) Measles virus-specific cellular immunity in patients with vaccine failure. J Clin Microbiol 31: 118–122
Zweiman B, Pappagianis D et al. (1971) Effect of measles immunization on tuberculin hypersensitivity and in vitro lymphocyte reactivity. Int Arch Allergy Appl Immunol 40: 834–841
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Griffin, D.E. (1995). Immune Responses During Measles Virus Infection. In: ter Meulen, V., Billeter, M.A. (eds) Measles Virus. Current Topics in Microbiology and Immunology, vol 191. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78621-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-78621-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78623-5
Online ISBN: 978-3-642-78621-1
eBook Packages: Springer Book Archive